A randomized trial of chemoradiotherapy and chemotherapy for locally advanced pancreatic cancer

A randomized trial of chemoradiotherapy and chemotherapy for locally advanced pancreatic cancer - A randomized trial for locally advanced pancreatic cancer

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001923

Enrollment

100

Registered

2009-04-30

Start date

2009-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

EBRT &amp

S-1 S-1 alone

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: histologically or cytologically confirmed adenocarcinoma of the pancreas;clinically or surgically staged and considered unresectable for cure;life expectancy greater than 6 months;measurable or assessable disease; life expectancy of > 3 months; adequate organ

Exclusion criteria

Exclusion criteria: active infection; severe heart disease; interstitial pneumonitis or pulmonary fibrosis; pleural effusion or ascites; active gastroduodenal ulcer; pregnant or lactating females; severe mental disorder; active concomitant malignancy; other serious medical conditions.

Design outcomes

Primary

Measure	Time frame
overall survival	—

Secondary

Measure	Time frame
progression-free survival tumor response toxicity	—

Countries

Japan

Contacts

Public ContactHiroyuki Shinchi

Kagoshima University Graduate School Department of Surgical Oncology and HBP Surgery

shinchi@m.kufm.kagoshima-u.ac.jp099-275-6756

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026